Get your health question answered instantly from our pool of 18000+ doctors from over 80 specialties
159 Doctors Online

By proceeding, I accept the Terms and Conditions

Dr. Andrew Rynne
MD
Dr. Andrew Rynne

Family Physician

Exp 50 years

HCM Blog Instant Access to Doctors
HCM BlogQuestions Answered
HCM Blog Satisfaction

How To Treat HCV,Quantitative Real Time PCR-338487 IU/ml With Genome Type-I?

My brother is undergoing hemodialysis twice a week for last 8 months. He is diagonised Hepatitis C Viral( HCV), Quantitatitative Real Time PCR- 338487 IU/ml with Genome Type-I. He is planning to undergo Kidney Transplatation. please suggest treatment.

Thanks

R.N Bhargava
Tue, 23 Aug 2016
Report Abuse
Nephrologist,  's  Response
Hi..First of all don't be tense. Luckily now a days very effective oral medication is available. For genotype 1 your doctor will prescribe ledipasavir/sofsobuvir medication. Start medication as early as possible. Go for transplant after completion of course which is generally 12-24 weeks. All the best. if you have any questions feel free to contact me.
I find this answer helpful
Note: For further queries related to kidney problems and comprehensive renal care, talk to a Nephrologist. Click here to Book a Consultation.
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer. For a more detailed, immediate answer, try our premium service [Sample answer]
Share on
 

Related questions you may be interested in


Recent questions on Hemodialysis


Loading Online Doctors....
How To Treat HCV,Quantitative Real Time PCR-338487 IU/ml With Genome Type-I?

Hi..First of all don t be tense. Luckily now a days very effective oral medication is available. For genotype 1 your doctor will prescribe ledipasavir/sofsobuvir medication. Start medication as early as possible. Go for transplant after completion of course which is generally 12-24 weeks. All the best. if you have any questions feel free to contact me.